benzothiazoline has been researched along with Leukemia, Myeloid, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albericio, F; Arnan, M; Cosialls, AM; Gamundi, E; Gil, J; González-Barca, EM; Iglesias-Serret, D; Lavilla, R; Moncunill-Massaguer, C; Núñez-Vázquez, S; Palmeri, CM; Pomares, H; Pons, G; Preciado, S; Saura-Esteller, J | 1 |
1 other study(ies) available for benzothiazoline and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Targeting prohibitins induces apoptosis in acute myeloid leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Differentiation; Cell Line, Tumor; Humans; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Prohibitins; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Tumor Cells, Cultured; Up-Regulation | 2016 |